Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (Endotoxin)

Critical Reviews in Microbiology

Volumn 24, Issue 4, 1998, Pages 281-334

  Kahler, Charlene M ^b   Stephens, David S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; GLYCOSYLTRANSFERASE; MENINGOCOCCUS VACCINE;

AMINO ACID SEQUENCE; ANTIGENIC VARIATION; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; CARBOHYDRATE ANALYSIS; CHROMOSOMAL LOCALIZATION; ENZYME REGULATION; GENE LOCUS; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID ANALYSIS; NEISSERIA MENINGITIDIS; NUCLEOTIDE SEQUENCE; OPERON; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TOXIN ANALYSIS;

BACILLI; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MENINGOCOCCUS; NEGIBACTERIA; NEISSERIA MENINGITIDIS;

EID: 0032411337     PISSN: 1040841X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408419891294216     Document Type: Review

References (263)

1. Robbins, A. and Freeman, P., Obstacles to developing vaccines for the Third World, Sci. Am., 259, 126-133, 1988.
2. Iversen, B. G. and Aavitsland, P., Meningococcal disease in Norway 1992-1995. Epidemiology and Fatality, Scand. J. Infect. Dis., 28, 253-259, 1996.
3. Jackson, L. A. and Wenger, J. D., Laboratory-based surveillance for meningococcal disease in selected areas, U.S., 1989-1991, Morbid. Mortal. Weekly Rep. Surv. Summ., 42, 21-30, 1993.
4. Jackson, L., Schuchat, A., and Wenger, J. D., Serogroup C meningococcal outbreaks in the US: epidemiology of an emerging threat, J. Am. Med. Assoc., 273, 383-389, 1995.p
5. Whalen, C. M., Hockin, J. C., Ryan, A., and Ashton, F., The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992, J. Am. Med. Assoc., 273, 390-394, 1995.
6. Pinner, R. W., Gellin, B. G., Bibb, W. F., Baker, C. N., Weaver, R., Hunter, S. B., Waterman, S. H., Mocca, L. F., Frasch, C. E., Broome, C. V., and The Meningococcal Disease Study Group, Meningococcal disease in the U.S. - 1986, J. Infect. Dis., 164, 368-374, 1991.
7. (CDC) Centers for Disease Control and Prevention, Summary of Notifiable Disease, U.S., Morbid. Mort. Weekly Rep, 45, 1997.
8. Achtman, M., Epidemic spread and antigenic variability of Neisseria meningitidis, Trends Microbiol., 3, 186-192, 1995.
9. Riou, J.-Y., Djibo, S., Sangare, L., Lombart, J.-P., Fagot, P., Chippaux, J.-P., and Guibourdenche, M., A predictable comeback: the second pandemic of infectioins caused by Neisseria meningitidis serogroup A subgroup III in Africa, 1995, Bull. WHO, 74, 181-187, 1996.
10. Pinner, R. W., Onango, F., Perkins, B. A., Mirza, N. B., Ngacha, D. B., Reeves, M., DeWitt, W., Njeru, E., Agata, N. N., Broome, C. V., and the Kenya/Centers for Disease Control (CDC) Meningitis Study Group, Epidemic meningococcal disease in Nairobi, Kenya, 1989., J. Infect. Dis., 166, 359-364, 1992.
11. Robbins, J. B., Towne, D. W., Gotschlich, E. C., and Schneerson, R., "Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa, Lancet, 350, 880-882, 1997.
12. World Health Organization, Meningitis in Africa. The constant challenge of epidemics, WHO Report, 21, 15, 1996.
13. Caugnant, D. A., Froholm, L. O., Bovre, K., Holten, E., Frasch, C. E., Mocca, L. F., Zollinger, W. D., and Selander, R. K., Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease, Proc. Natl. Acad. Sci. U.S.A., 83, 4927-4231, 1986.
14. Hedberg, K., Hoesly, F., Fleming, D., Steingart, K., Goldoft, M., and Stehr-Green, P., Serogroup B meningococcal disease - Oregon, 1994, Morbid. Mortal. Weekly Rep., 44, 121-124, 1995.
15. Saez-Nieto, J. A., Lujan, R., Berron, S., Campos, J., Vinas, M., Fuste, C., Vazquez, J. A., Zhang, Q. Y., Bowler, L. D., Martinez-Suarez, J. V., and Spratt, B.G., Epidemiology and molecular basis of penicillin-resistant Neisseria meningitidis in Spain: a 5-year history (1985-1989), Clin. Infect. Dis., 14, 394-402, 1992.
16. Dillon, J. R., Pauze, M., and Yeung, K.-H., Spread of penicillin-producing and plasmid transfer from the meningococcus to Neisseria meningitidis, Lancet, 1, 779-781, 1983.
17. Knapp, J. S., Johnson, S. R., Zenilman, J. M., Roberts, M. C. and Morse, S. A., High-level tetracycline resistance resulting from TetM in strains of Neisseria spp., Kingella dentrificans and Eikenella corroders, Antimicrob. Agent. Chemother., 32, 765-767, 1988.
18. Oppenheim, B. A., Antibiotic resistance in Neisseria meningitidis, Clin. Infect. Dis, 24(Suppl. 1), S98-S101, 1997.
19. Blondeau, J. M., Ashton, F. E., Isaacson, M., Yaschuck, Y., Anderson, C., and Ducasse, G., Neisseria meningitidis with decreased susceptibility to penicillin in Saskatchewan, Canada, J. Clin. Microbiol., 33, 1784-1786, 1995.
20. Galiamnd, M., Gerbaud, G., Guibourdenche, M., Riou, J. Y., and Courvalin, P., High-level chloramphenicol resistance in Neisseria meningitidis, N. Engl. J. Med., 339, 868-874, 1998.
21. Cuevas, L. E., Kazembe, P., Mughogho, G. K., Tilloston, G. S., and Hart, C. A., Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: a comparison of ciprofloxacin and rifampicin, J. Infect. Dis., 171, 728-731, 1995.
22. Enting, R. H., Spanjaard, L., van de Beek, D., Hensen, E. F., de Gans, J., and Dankert, J., Antimicrobial susceptibility of Haemophilus influenzae, Neisseria meningitidis and Streptococcus pneumoniae isolates causing meningitis in The Netherlands, 1993-1994, J. Antimicrob. Chemother., 38, 777-786, 1996.
23. Horn, D. L., Opal, S. M., and Lomastro, E., Antibiotics, cytokines, and endotoxin: a complex and evolving relationship in Gram-negative sepsis, Scand. J. Infect. Dis. Sup., 101, 9-13, 1996.
24. Mitchell, L. A., Ochnio, J. J., Glover, C., Lee, A. Y., Ho, M.K.-L., and Bell, A., Analysis of meningococcal serogroup C-specific antibody levels in British Columbian children and adolescents, J. Infect. Dis., 173, 1009-1013, 1996.
25. Poolman, J. T., Development of a meningococcal vaccine, Infect. Agent. Dis., 4, 13-28, 1995.
26. Finne, J., Bitter-Suermann, D., Goridis, C., and Finne, U., An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues, J. Immunol, 138, 4402-4407, 1987.
27. Mandrell, R. E., Azmi, F. H., and Granoff, D. M., Complement-mediated bactericidal activity of human antibodies to poly α2-8 N-acetylneuraminic acid, the capsular polysaccharide of Neisseria meningitidis serogroup B, J. Infect. Dis., 172, 1279-1289, 1995.
28. Hayrinen, J., Jennings, H., Raff, H. V., Rougon, G., Hanai, N., Gerardy-Schahn, R., and Finne, J., Antibodies to polysialic acid and its N-propyl derivative: binding properties and interaction with human embryonal brain glycopeptides, J. Infect. Dis., 171, 1481-1490, 1995.
29. DeVoe, I. W., The meningococcus and mechanisms of pathogenicity, Microbiol. Rev., 46, 162-190, 1982.
30. Stephens, D. S. and Farley, M. M., Pathogenic events during infection of the human nasopharynx with Neisseria meningitidis and Haemophilus influenzae, Rev. Infect. Dis., 13, 22-33, 1991.
31. Cartwright, K. A. V., Stuart, J. M., Jones, D. M., and Noah, N. D., The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica, Epidem. Infect., 99, 591-601, 1987.
32. Greenfield, S., Sheehe, P. R., and Feldman, H. A., Meningococcal carriage in a population of "normal" families, J. Infect. Dis., 123, 67-73, 1971.
33. Gauld, J. R., Nitz, R. E., Hunter, D. H., Rust, J. H., and Gauld, R. L., Epidemiology of meningococcal meningitis at Fort Ord, Am. J. Epidem., 82, 56-72, 1965.
34. Slaterus, K. W., Ruys, A. C., and Sieberg, I. G., Types of meningococci isolated from carriers and patients in a nonepidemic period in the Netherlands, Antonie Leenwenhoek, 29, 265-271, 1963.
35. Goldschneider, I., Gotschlich, E. C., and Artenstein, M., Human immunity to the meningococcus. I. The role of humoral antibodies, J. Exp. Med., 129, 1307-1326, 1969.
36. Goldschneider, I., Gotschlich, E. C., and Artenstein, M. S., Human immunity to the meningococcus. II. Development of natural immunity, J. Exp. Med., 129, 1327-1348, 1969.
37. Reller, L. B., MacGregor, R. R., and Beaty, H. N., Bactericidal antibody after colonization with Neisseria meningitidis, J. Infect. Dis., 127, 56-62, 1973.
38. Gold, R., Goldschneider, I., Lepow, M. L., Draper, T. F., and Randolf, M., Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children, J. Infect. Dis., 137, 112-121, 1978.
39. Jones, D. M. and Mallard, R. H., Age incidence of meningococcal infection England and Wales, 1984-1991, J. Infect., 27, 83-88, 1993.
40. Saarinen, M., Takala, A., Koskenniemi, E., Kela, E., Ronnberg, P.-R., Pekkanen, E., Kiiski, P., Eskola, J., and The Finnish Pediatrie Invasive Infection Study Group, Spectrum of 2,836 cases of invasive bacterial or fungal infections in children: results of prospective nationwide five-year surveillance in Finland, Clin. Infect. Dis., 21, 1134-1144, 1995.
41. Rayner, C. F. J., Dewar, A., Moxon, E. R., Virji, M., and Wilson, R., The effect of variations in the expression of pili on the interaction of Neisseria meningitidis with human nasopharyngeal epithelium, J. Infect. Dis., 171, 113-121, 1995.
42. Stephens, D. S., Hoffman, L. H., and McGee, Z. A., Interaction of Neisseria meningitidis with human nasopharyngeal mucosa: attachment and entry into columnar epithelial cells, J. Infect. Dis., 148, 369-376, 1983.
43. Stephens, D. S. and McGee, Z. A., Attachment of Neisseria meningitidis to human mucosal surfaces: influence of pili and type of receptor cell, J. Infect. Dis., 143, 525-532, 1981.
44. Nassif, X., Beretti, J.-L., Lowy, J., Stenberg, P., O'Gaora, P. J., Normark, S., and So, M., Roles of pilin and PilC in adhesion of Neisseria meningitidis to human epithelial and endothelial cells, Proc. Natl. Acad. Sci., 91, 3769-3773, 1994.
45. Craven, D. E., Peppler, M. S., Frasch, C. E., Mocca, L. F., McGrath, P. P., and Washington, G., Adherence of isolates of Neisseria meningitidis from patients and carriers to human buccal cells, J. Infect. Dis., 142, 556-557, 1980.
46. de Vries, F. P., van der Ende, A., van Putten, J. P. M., and Dankert, J., Invasion of primary nasopharyngeal epithelial cells by Neisseira meningitidis is controlled by phase variation of multiple surface antigens, Infect. Immun., 64, 2998-3006, 1996.
47. Salit, I. E. and Morton, G., Adherence of Neisseria meningitidis to huamn epithelial cells, Infect. Immun., 31, 430-435, 1981.
48. Salit, I. E. and Tomalty, L., Experimental meningococcal infections in mice: a model for mucosal invasion, Infect. Immun., 51, 648-652, 1986.
49. Virji, M., Makepeace, K., Ferguson, D. J. P., Achtman, M., and Moxon, E. R., Meningococcal Opa and Ope proteins: their role in colonization and invasion of human epithelial and endothelial cells, Mol. Microbiol., 10, 499-510, 1993.
50. Virji, M., Makepeace, K., Ferguson, D. P., and Watt, S. M., Carcinoembryonic antigens (CD66) on epithelial cells and neutrophils are receptors for Opa proteins of pathogenic neisseriae, Mol. Microbiol., 22, 941-950, 1996.
51. Virji, M., Alexandrescu, C., Ferguson, D. J. P., Saunders, J. R., and Moxon, E. R., Variations in the expression of pili: the effect on adherence of Neisseria meningitidis to human epithelial and endothelial cells, Mol. Microbiol., 6, 1271-1279, 1992.
52. Stephens, D. S., Whitney, A. M., Melly, M. A., Hoffman, L. H., Farley, M. M., and Frasch, C. E., Analysis of damage to human ciliated nasopharyngeal epithelium by Neisseria meningitidis, Infect. Immun., 51, 579-585, 1986.
53. Dunn, K. L. R., Virji, M., and Moxon, E. R., Investigations into the molecular basis of meningococcal toxicity for human endothelial and epithelial cells: the synergistic effect of LPS and pili, Microb. Pathog., 18, 81-96, 1995.
54. Virji, M., Makepeace, K., Peak, I. R. A., Ferguson, D. J. P., Jennings, M. P., and Moxon, E. R., Opc-and pilus-dependent interactions of meningococci with human endothelial cells: molecular mechanisms and modulation of surface polysaccharides, Mol. Microbiol., 18, 741-754, 1995.
55. Achtman, M., Wall, R. A., Bopp, M., Kusecek, B., Morelli, G., Saken, E., and Hussan-King, M., Variation in Class 5 protein expression by serogroup A meningococci during a meningitis epidemic, J. Infect. Dis., 164, 375-382, 1991.
56. Tinsley, C. R. and Heckels, J. E., Variation in the expression of pili and outer membrane protein by Neisseria meningitidis during the course of meningococcal infection, J. Gen. Microbiol., 132, 2483-2490, 1986.
57. Virji, M., Makepeace, K., and Moxon, E. R., Distinct mechanisms of interactions of Opc-expressing meningococci at apical and basolateral surfaces of human endothelial cells; the role of integrins in apical interactions, Mol. Microbiol., 14, 173-184, 1994.
58. Stephens, D. S., Spellman, P. A., and Swartley, J. S., Effect of the (α2-8)-linked polysialic acid capsule on adherence of Neisseria meningitidis to human mucosal cells, J. Infect. Dis., 167, 475-479, 1993.
59. Masson, L. and Holbein, B. E., Influence of nutrient limitation and low pH on serogroup B Neisseria meningitidis capsular polysaccharide levels: correlation with virulence for mice, Infect. Immun., 47, 465-471, 1985.
60. Masson, L. and Holbein, B. E., Influence of environmental conditions on serogroup B Neisseria meningitidis capsular polysaccharide levels, in The Pathogenic Neisseria, Schoolnik, G. K. et al., Eds. American Society of Microbiology, Washington, DC, 1985, 571-578.
61. Hilse, R., Hammerschmidt, S., Bautsch, W., and Frosch, M., Site-specific insertion of IS1301 and distribution in Neisseria meningitidis strains, J. Bacteriol., 178, 2527-2532, 1996.
62. Hammerschmidt, S., Hilse, R., van Putten, J. P. M., Gerardy-Schahn, R., Unkmeir, A., and Frosch, M., Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element, EMBO J., 15, 192-198, 1996.
63. McGee, D. J. and Rest, R. F., Regulation of gonococcal sialyltransferase, lipooligosaccharide, and serum resistance by glucose, pyruvate, and lactate, Infect. Immun., 64, 4630-3637, 1996.
64. Stanwell-Smith, R. E., Stuart, J. M., Hughes, A. O., Robinson, P., Griffin, M. B., and Cartwright, K., Smoking, the environment and meningococcal disease: a case control study, Epidem. Infect., 112, 315-328, 1994.
65. Cartwright, K. A. V., Jones, D. M., Smith, A. J., Stuart, J. M., Kaczmarski, E. B., and Palmer, S. R., Influenza A and meningococcal disease, Lancet, 338, 406-409, 1991.
66. Moore, P. S., Hierholzer, J., DeWitt, W., Gouanik, K., Djore, D., Lippeveld, T., Plikagtis, B., and Broome, C. V., Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis, J. Am. Med. Assoc., 264, 1271-1275, 1990.
67. MacKinnon, F. G., Borrow, R., Gorringe, A. R., Fox, A. J., Jones, D. M., and Robinson, A., Demonstration of lipooligosaccharide immunotype and capsule as virulence factors for Neisseria meningitidis using an infant mouse intranasal infection model, Microb. Pathog., 15, 359-366, 1993.
68. Lehner, P., Davies, K. A., Walport, M. J., Cope, A. P., Wurzner, R., Orren, A., Morgan, B. P., and Cohen, J., Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release, Lancet, 340, 1379-1381, 1992.
69. Sjoholm, A. G., Braconier, J. H., and Soderstrom, C., Properdin deficiency in a family with fulminant meningococcal infections, Clin. Exp. Immunol., 50, 291-197, 1982.
70. Griffiss, J. M., Broud, D. D., and Bertram, M. A., Bactericidal activity of meningococcal antisera. Blocking by IgA of lytic antibody in human convalescent sera, J. Immunol., 114, 1779-1784, 1975.
71. Cooper, N. R. and Morrison, D. C., Binding and activation of the first component of human complement by the lipid A region of lipopolysaccharides, J. Immunol., 120, 1862-1868, 1978.
72. Shafer, W. M., Joiner, K., Guymon, L. F., Cohen, M. S., and Sparling, P. F., Serum sensitivity of Neisseria gonorrhoeae: the role of lipopolysaccharide, J. Infect. Dis., 149, 175-183, 1984.
73. Brown, E. J., Complement receptors and phagocytosis, Curr. Opin. Immunobiol., 3, 76-82, 1991.
74. Kim, J. J., Zhou, D., Mandrell, R. E., and Griffiss, J. M., Effect of exogenous sialylation of the lipooligosaccharide of Neisseria gonorrhoeae on opsonophagocytosis, Infect. Immun., 60, 4439-4442, 1992.
75. Ross, S. C., Rosenthal, P. J., Berberich, H. M., and Densen, P., Killing of Neisseria meningitidis by human neutrophils: implications for normal and complement-deficient individuals, J. Infect. Dis., 155, 1266-1275, 1987.
76. Jones, D. M., Borrow, R., Fox, A. J., Gray, S., Cartwright, K. A., and Poolman, J. T., The lipooligosaccharide immunotype as a virulence determinant in Neisseria meningitidis, Microb. Pathog., 13, 219-224, 1992.
77. Vogel, U., Hammerschmidt, S., and Frosch, M., Sialic acids of both the capsule and the sialylated lipooligosaccharide of Neisseria meningitidis serogroup B are prerequisites for virulence of meningococci in the infant rat, Med. Microbiol. Immunol., 185, 81-87, 1996.
78. Klein, N. J., Ison, C. A., Peakman, M., Levin, M., Hammerschmidt, S., Frosch, M., and Heyderman, R. S., The influence of capsulation and lipooligosaccharide structure on neutrophil adhesion molecule expression and endothelial injury by Neisseria meningitidis, J. Infect. Dis., 173, 172-179, 1996.
79. Moran, E. E., Brandt, B. L., and Zollinger, W. D., Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity, Infect. Immun., 62, 5290-5295, 1994.
80. Griffiss, J. M., Schneider, H., Mandrell, R. E., Yamasaki, R., Jarvis, G. A., Kim, J. J., Gibson, B. W., Hamadeh, R., and Apicella, M. A., Lipooligosaccharides: The principle glycolipids of the neisserial outer membrane, Rev. Infect. Dis., 10, S287-S295, 1988.
81. Verheul, A. F. M., Poolman, J. T., Snippe, H., and Verhoff, J., The influence of the adjuvant Quil A on the epitope specificity of meningococcal lipopolysaccharide anti-carbohydrate antibodies, Mol. Immunol., 28, 1193-1200, 1991.
82. Jarvis, G. A. and Vedros, N. A., Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation, Infect. Immun., 55, 174-180, 1987.
83. McNeil, G., Virji, M., and Moxon, E. R., Interactions of Neisseria meningitidis with human monocytes, Microb. Pathog., 16, 153-163, 1994.
84. Read, R. C., Zimmerli, S., Broaddus, V. C., Sanan, D. A., Stephens, D. S., and Ernst, J. D., The (α2-8) linked polysialic acid capsule of group B Neisseria meningitidis modifies multiple steps during interaction with human macrophages, Infect. Immun., 64, 3210-3217, 1996.
85. Estabrook, M. M., Griffiss, J. M., and Jarvis, G. A., Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose, Infect. Immun., 65, 4436-4444, 1997.
86. Vogel, U., Weinberger, A., Frank, R., Muller, A., Kohl, J., Atkinson, J. P., and Frosch, M., Complement factor deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis, Infect. Immun., 65, 4022-4029, 1997.
87. Ram, S., Sharma, A. K., Simpson, S. D., Gulati, S., McQuillen, D. P. Pangburn, M. K., and Rice, P. A., A novel sialic acid binding site on factor H mediates serum resistence of sialylated Neisseria gonorrhoeae, J. Exp. Med., 187, 743-752, 1998.
88. Kahler, C. M., Martin, L. E., Shih, G., Carlson, R. W., and Stephens, D. S., Both (α2-8)-linked polysialic acid capsule and α-chain lipooligosaccharide structures that obscure or replace lacto-N-neotetraose are required for serogroup B Neisseria meningitidis resistance to the bactericidal acitivty of normal human serum, Infect. Immun., in press, 1998.
89. Brandtzaeg, P., Kierulf, P., Gaustad, P., Skulberg, A., Bruun, J. N., Halvorsen, S., and Sorensen, E., Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease, J. Infect. Dis., 159, 195-203, 1989.
90. Brandtzaeg, P., Ovstebo, R. and Kierulf, P., Bacteremia and compartmentalization of LPS in meningococcal disease, in Bacterial Endotoxins: Lipopolysaccharides from Genes to Therapy, Levin, J., Alving, C. R., Munford, R. S., and Redl, H., Eds. Wiley-Liss, Inc., New York, 1995, 219-233.
91. van Deuren, M., van der Ven-Jongekrijg, J., Bartelink, A. K. M., van Dalen, R., Sauerwein, R. W., and van der Meer, J. W. M., Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections, J. Infect. Dis., 172, 433-439, 1995.
92. Devoe, I. W. and Gilchrist, J. E., Release of endotoxin in the form of cell wall blebs during in vitro growth in Neisseria meningitidis, J. Exp. Med., 138, 1156-1167, 1973.
93. Brandtzaeg, P., Halstensen, A., Kierulf, P., Espevik, T., and Waage, A., Molecular mechanisms in the compartmentalized inflammatory response presenting as meningococcal meningitis or septic shock, Microb. Pathog., 13, 423-431, 1992.
94. Wurfel, M. M., Hailman, E., and Wright, S. D., Soluble CD 14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein, J. Exp. Med., 181, 1743-1754, 1995.
95. Viriyakosol, S. and Kirkland, T., Knowledge of cellular receptors for bacterial endotoxin - 1995, Clin. Infect. Dis., 21, S190-S195, 1995.
96. Berton, G., Yan, S. R., Fumagalli, L., and Lowell, C. A., Neutrophil activation by adhesion: mechanisms and pathophysiological implications, Intern. J. Clin. Lab. Res., 26, 160-177, 1996.
97. Proost, P., Wuyts, A., and van Damme, J., The role of chemokines in inflammation, Intern. J. Clin. Lab. Res., 26, 211-223, 1996.
98. Brandtzaeg, P., Hogasen, K., Kierulf, P., and Mollnes, T. E., The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation, J. Infect. Dis., 173, 647-655, 1996.
99. Kornelisse, R. F., Hazelet, J. A., Savelkoul, H. F. J., Hop, W. C. J., Suur, M. H., Borsboom, A. N. J., Risseeuw-Appel, I. M., van der Voort, E., and de Groot, R., The relationship between plasminogen activator inhibitor-1 and proinflammatory and counter-inflammatory mediators in children with meningococcal septic shock, J. Infect. Dis., 173, 1148-1156, 1996.
100. Lehmann, A. K., Halstensen, A., Sornes, S., Rokke, O., and Waage, A., High levels of interleukin 10 in serum are associated with fatality in meningococcal disease, Infect. Immun., 63, 2109-2112, 1995.
101. Bredius, R. G. M., Derkx, B. H. F., Fijen, C. A. P., de Wit, T. P. M., de Haas, M., Weening, R. S., van de Winkel, J. G. J., and Out, T. A., Fcγ receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children, J. Infect. Dis., 170, 848-853, 1994.
102. Nadel, S., Newport, M. J., Booy, R., and Levin, M., Variation in the tumor necrosis factor-α gene promoter region may be associated with death from meningococcal disease, J. Infect. Dis., 174, 878-880, 1996.
103. Horwitz, A. H., Williams, R. E., and Nowakowski, G., Human lipopolysaccharide-binding protein potentiates bactericidal activity of human bactericidal/permeability-increasing protein, Infect. Immun., 63, 522-527, 1995.
104. Cunningham, M. D., Seachord, C., Ratcliffe, K., Bainbridge, B., Aruffo, A., and Darveau, R. P., Helicobacter pylori and Porphyromonas gingivalis lipopolysaccharides are poorly transferred to recombinant soluble CD 14, Infect. Immun., 64, 3601-3608, 1996.
105. 23, Infect. Immun., 63, 2201-2205, 1995.
106. Toumanen, E., Entry of pathogens into the central nervous system, FEMS Microbiol. Rev., 18, 289-299, 1996.
107. Hill, W. R. and Kinney, T. D., The cutaneous lesions in acute meningococcemia, J. Am. Med. Assoc., 134, 513-518, 1947.
108. Quagliaroello, V. and Scheld, W. M., Bacterial meningitis: pathogensis, pathophysiology, and progress, N Engl. J. Med., 327, 864-872, 1992.
109. Wilkinson, S. G., Bacterial lipopolysaccharides - themes and variations, Prog. Lipid Res., 35, 283-343, 1996.
110. Jennings, H. J., Bhattacharjee, A. K., Kenne, L., Kenny, C. P., and Calver, G., The R-type lipopolysaccharides of Neisseria meningitidis, Can. J. Biochem., 58, 128-136, 1980.
111. Maskell, D., Allen, A., Khan, S., and Servos, S., Molecular genetic manipulation of nonenteric bacterial pathogens to synthesize altered lipopolysaccharide molecules, in Bacterial Endotoxins: Lipopolysaccharides from Genes to Therapy, Levin, J., Alving, C. R., Munford, R. S., and Redl, H., Eds. Wiley-Liss, Inc., 1995, 35-47.
112. Aspinall, G. O., McDonald, A. G., Raju, T. S., Pang, H., Mills, S. D., Kurjanczyk, L. A., and Penner, J. L., Serological diversity and chemical structure of Campylobacter jejuni low-molecular-weight lipopolysaccharides, J. Bacteriol., 174, 1324-1332, 1992.
113. Schweda, E. K. H., Jonasson, J. A., and Jansson, P.-E., Structural studies of lipooligosaccharides from Haemophilus ducreyi ITM 5535, ITM 3147, and a fresh clinical isolate, ACY1: evidence for intrastrain heterogeneity with the production of mutually exclusive sialylated or elongated glycoforms, J. Bacteriol., 177, 5316-5321, 1995.
114. Preston, A., Mandrell, R. E., Gibson, B. W., and Apicella, M. A., The lipooligosaccharides of pathogenic Gram-negative bacteria, Crit. Rev. Microbiol., 22, 139-180, 1996.
115. Campagnari, A. A., Spinola, S. M., Lesse, A. J., Kwaik, Y. A., Mandrell, R. E., and Apicella, M. A., Lipooligosaccharide epitopes shared among Gram-negative non-enteric mucosal pathogens, Microb. Pathog., 8, 353-362, 1990.
116. Hisatsune, K., Kondo, S., Isshiki, Y., Iguchi, T., Kawamata, Y., and Shimada, T., O-antigenic lipopolysaccharide of Vibrio cholerae O139 Bengal, a new epidemic strain for recent cholera in the Indian subcontinent, Biochem. Biophys. Res. Comm., 196, 1309-1315, 1993.
117. Evans, D. J., Pier, G. B., Coyne, M. J., Jr., and Goldberg, J. B., The rfb locus from Pseudomonas aeruginosa strain PA103 promotes the expression of O antigen by both LPS-rough and LPS-smooth isolates from cystic fibrosis patients, Mol. Microbiol., 13, 427-434, 1994.
118. Schneider, H., Hale, T. L., Zollinger, W. D., Seid, R. C., Jr., Hammack, C. A., and Griffiss, J. M., Heterogeneity of molecular size and antigenic expression within lipooligosaccharides of individual strains of Neisseria gonorrhoeae and Neisseria meningitidis, Infect. Immun., 45, 544-549, 1984.
119. Meyer, T. F., Gibbs, C. P., and Haas, R., Variation and control of protein expression in Neisseria, Ann. Rev. Microbiol., 44, 451-477, 1990.
120. Mandrell, R. E. and Zollinger, W. D., Lipopolysaccharide serotyping of Neisseria meningitidis by hemagglutination inhibition, Infect. Immun., 16, 471-475, 1977.
121. Zollinger, W. D. and Mandrell, R. E., Outer-membrane protein and lipopolysaccharide serotyping of Neisseria meningitidis by inhibition of a solid-phase radioimmunoassay, Infect. Immun., 18, 424-433, 1977.
122. Zollinger, W. D. and Mandrell, R. E., Type-specific antigens of group A Neisseria meningitidis: lipopolysaccharide and heat modifiable outer membrane proteins, Infect. Immun., 28, 451-458, 1980.
123. Tsai, C.-M., Mocca, L. F., and Frasch, C. E., Immunotype epitopes of Neisseria meningitidis lipooligosaccharide types 1 through 8, Infect. Immun., 55, 1652-1656, 1987.
124. Yamasaki, R., Bacon, B. E., Nasholds, W., Schneider, H., and Griffiss, J. M., Structural determination of oligosaccharides derived from lipooligosaccharide of Neisseria gonorrhoeae F62 by chemical, enzymatic, and two-dimensional NMR methods, Biochemistry, 30, 10566-10575, 1991.
125. Yamasaki, R., Kerwood, D. E., Schneider, H., Quinn, K. P., Griffiss, J. M., and Mandrell, R. E., The structure of lipooligosaccharide produced by Neisseria gonorrhoeae, strain 15253, isolated from a patient with disseminated infection, J. Biol. Chem., 269, 30345-30351, 1994.
126. Payton, J. J. and Stein, D. C., Lipooligosaccharide expression in Neisseria gonorrhoeae strain PID2, in Abstracts of the Eleventh International Pathogenic Neisseria Conference, Nassif, X., Quentin-Millet, M.-J. Taha, M.-K., Eds., Nice, 294, 1998.
127. Tong, Y., Arking, D., and Stein, D. C., Some nonpathogenic Neisseria sp. possess the genetic ability to express gonococcal and meningococcal-like LOS structures, in Abstracts of the Eleventh International Pathogenic Neisseria Conference, Nassif, X., Quentin-Millet, M.-J., Taha, M.-K., Eds., Nice, 299, 1998.
128. Griffiss, J. M., Brandt, B., Engstrom, J., Schneider, H., Zollinger, W., and Gibson, B., Structural relationships and sialylation among meningococcal lipopolysaccharide (LOS) serotypes, in Proceedings of the Ninth International Pathogenic Neisseria Conference, Evans, J. S., Yost, S., Maiden, M. C. J., and Feavers, I. M., Eds. Winchester, England, 1994, 12.
129. Mandrell, R. E., Griffiss, J. M., and Macher, B. A., Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens, J. Exp. Med., 168, 107-126, 1988.
130. Tsai, C.-M. and Civin, C. I., Eight lipooligosaccharides of Neisseria meningitidis react with a monoclonal antibody which binds lactoN-neotetraose (Galβ1-4GlcNAcβ1-3Galβ1-4Glc), Infect. Immun., 59, 3604-3609, 1991.
131. Verheul, A. F. M., Snippe, H., and Poolman, J. T., Meningococcal lipopolysaccharides: virulence factor and potential vaccine component, Micobiol Rev., 57, 34-49, 1993.
132. Mandrell, R. E., Lesse, A. J., Sugai, J. V., Shero, M., Griffiss, J. M., Cole, J. A., Parsons, N. J., Smith, H., Morse, S. A., and Apicella, M. A., In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation, J. Exp. Med., 171, 1649-1664, 1990.
133. Mandrell, R. E., Griffiss, J. M., Smith, H., and Cole, J. A., Distribution of a lipooligosaccharide-specific sialyltransferase in pathogenic and non-pathogenic Neisseria, Microb. Pathog., 14, 315-327, 1993.
134. Wakarchuk, W., Gilbert, M., Martin, A., Wu, Y., Brisson, J.-R., Thibault, P., and Richards, J. C., Structure of an α2,6-sialylated lipooligosaccharide from Neisseria meningitidis immunotype L1, Eur. J. Biochem., 254, 626-633, 1998.
135. Schneider, H., Cross, A. S., Kuschner, R. A., Taylor, D. N., Sadoff, J. C., Boslego, J. W., and Deal, C. D., Experimental human gonococcal urethritis: 250 Neisseria gonorrhoeae MS11mkC are infective, J. Infect. Dis., 172, 180-185, 1995.
136. Kulshin, V. A., Zahringer, U., Linder, B., Frasch, C. E., Tsai, C.-M., Dmitriev, B. A., and Rietschel, E. T., Structural characterization of the Lipid A component of pathogenic Neisseria meningitidis, J. Bacteriol., 174, 1793-1800, 1992.
137. Raetz, C. R. H., Biochemistry of endotoxins, Ann. Rev. Biochem., 59, 129-170, 1990.
138. Takayama, K., Qureshi, N., Hyver, K., Honovich, J., Cotter, R. J., Mascagni, P., and Schneider, H., Characterization of a structural series of Lipid A obtained from the lipopolysaccharides of Neisseria gonorrhoeae, J. Biol. Chem., 261, 10624-10631, 1986.
139. 5S No. 125, Arch. Microbiol., 157, 131-134, 1992.
140. Rahman, M. M., Stephens, D. S., Kahler, C. M., Gluska, J., and Carlson, R. W., The structural heterogeneity of the lipooligosaccharide (LOS) of Neisseria meningitidis serogroup B: substituents of the inner core, Carbohyd. Res, 307, 311-324, 1998.
141. Ogawa, T., Chemical structure of lipid A from Porphyromonas (Bacteroides) gingivalis lipopolysaccharide, FEBS Lett., 332, 197-201, 1993.
142. Weintraub, A., Zahringer, U., Wollenweber, H.-W., Seydel, U., and Rietschel, E. T., Structural characterization of the lipid A component of Bacterioides fragilis strain NCTC 9343 lipopolysaccharide, Eur. J. Biochem., 183, 425-432, 1989.
143. Raetz, C. R., Bacterial lipopolysaccharides: a remarkable family of bioactive macroamphiphiles, in Escherichia coli and Salmonella: Cellular and Molecular Microbiology, Neidhardt, F. C., Eds. ASM Press, Washington, D.C., 1996, 1035-1063
144. Takayama, K., Qureshi, N., Raetz, C. R. H., Ribi, E., Peterson, J., Cantrell, J. L., Pearson, F. C., Wiggins, J., and Johnson, A. G., Influence of fine structure of lipid A on Limulus ameobocyte lysate clotting and toxic activities, Infect. Immun., 45, 350-355, 1984.
145. Rietschel, E. T., Kirikae, T., Schade, F. U., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A. J., Zahringer, U., Seydel, U., di Padova, F., Schreier, M., and Brade, H., Bacterial endotoxin: molecular relationships of structure to activity and function, FASEB J., 8, 217-225, 1994.
146. Roth, R. I., Yamasaki, R., Mandrell, R. E. and Griffiss, J. M., Ability of gonococcal and meningococcal lipooligosaccharides to clot Limulus amebocyte lysate, Infect. Immun., 60, 762-767, 1992.
147. Bihlmaier, A., Romling, U., Meyer, T. F., Tummler, B., and Gibbs, C. P., Physical and genetic map of the Neisseria gonorrhoeae strain MS11-N198 chromosome, Mol. Microbiol., 5, 2529-2539, 1991.
148. Dempsey, J. A. F., Wallace, A. B., and Cannon, J. G., The physical map of the chromosome of a serogroup A strain of Neisseria meningitidis shows complex rearrangements relative to the chromosomes of the two mapped strains of the closely related species N. gonorrhoeae, J. Bacteriol., 177, 6390-6400, 1995.
149. Gaher, M., Einsiedler, K., Crass, T., and Bautsch, W., A physical and genetic map of Neisseria meningitidis B1940, Mol. Microbiol., 19, 249-259, 1996.
150. Gibbs, C. P. and Meyer, T. F., Genome plasticity in Neisseria gonorrhoeae, FEMS Microbiol. Lett., 145, 173-179, 1996.
151. Kahler, C. M. and Stephens, D. S., unpublished.
152. Tinsley, C. R. and Nassif, X., Analysis of the genetic differences between Neisseria meningitidis and Neisseria gonorrhoeae: two closely related bacteria expressing two different pathogenicities, Proc. Natl. Acad. Sci. U.S.A., 93, 11109-11114, 1996.
153. Roe, B. A., Clifton, S., and Dyer, D. W., Gonococcal Genome Sequencing Project (http://www.genome.ou.edu), 1998.
154. N. meningitidis Sequencing Group at the Sanger Center (ftp://ftp.sanger.ac.uk/pub/pathogens/ nm/)., 1998.
155. Reeves, P. R., Hobbs, M., Valvano, M. A., Skurnik, M., Whitfield, C., Coplin, D., Kido, N., Klena, J., Maskell, D., Raetz, C. R. H., and Rick, P.D., Bacterial polysaccharide synthesis and gene nomenclature, Trend. Microbiol., 4, 495-503, 1996.
156. Mengin-Lecreulx, D. and Heijenoort, J., Copurification of glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase activities of Escherichia coli: characterization of the glmU gene product as a bifunctional enzyme catalyzing two subsequent steps in the pathway for UDP-N-acetylglucosamine synthesis, J. Bacteriol., 176, 5768-5795, 1994.
157. Ullrich, J. and van Putten, J. P. M., Identification of the gonococcal glmU gene encoding the enzyme N-acetylglucosamine 1-phosphate uridyltransferase
158. Berlyn, M. K. B., Low, K. B., and Rudd, K. E., Linkage map of Escherichia coli K-12, Edition 9, in Escherichia coli and Salmonella: Cellular and Molecular Biology, Neidhardt, F. C., Eds. ASM Press, Washington, D.C., 1996, 1715-1902.
159. Steeghs, L., Jennings, M. P., Poolman, J. T., and van der Ley, P., Isolation and characterization of the Neisseria meningitidis lpxD-fabZ-lpxA gene cluster involved in lipid A biosynthesis, Gene, 190, 263-270, 1997.
160. Odegaard, T. J., Kaltashov, I. A., Cotter, R. J., Steeghs, L., van der Ley, P., Khan, S., Maskell, D. J., and Raetz, C. R. H., Shortened hydroxyacyl chains on lipid A of Escherichia coli cells expressing a foreign UDP-N-acetylglucosamine O-acyltransferase, J. Biol. Chem., 272, 19688-19696, 1997.
161. Steeghs, L., den Hartog, R., den boer, A., Zomer, B., Roholl, P., and van der Ley, P., Meningitis bacterium is viable without endotoxin, Nature, 392, 449-450, 1998.
162. Garrett, T. A., Kadrmas, J. L., and Raetz, C. R. H., Identification of the gene encoding the Escherichia coli lipid A 4′-kinase. Facile phosphorylation of endotoxin analogs with recombinant LpxK, J. Biol. Chem., 272, 21855-21864, 1997.
163. Subramaniam, P. S., Xie, G., Xia, T., and Jensen, R. A., Substrate ambiguity of 3-deoxy-D-manno-octulosonate 8-phosphate synthase from Neisseria gonorrhoeae in the context of its membership in a protein family containing a subset of 3-deoxy-D-arabino-heptulsonate 7-phosphate synthases, J. Bacteriol., 180, 119-127, 1998.
164. Belunis, C. J. and Raetz, C. R. H., Biosynthesis of endotoxins: purification and catalytic properties of 3-deoxy-D-manno-octulosonic acid transferase from Escherichia coli, J. Biol. Chem., 267, 9988-9997, 1992.
165. van der Ley, P., Hamstra, H. J., and Steeghs, L., Modification of lipid A biosynthesis in Neisseria meningitidis in Abstracts of the Eleventh International Pathogenic Neisseria Conference, Nassif, X., Quentin-Millet, M.-J., Taha, M.-K., Eds., Nice, 27, 1998.
166. Brooke, J. S. and Valvano, M. A., Biosynthesis of inner core lipopolysaccharide in enteric bacteria identification and characterization of a conserved phosphoheptose isomerase, J. Biol. Chem., 271, 3608-3614, 1996.
167. Brooke, J. S. and Valvano, M. A., Molecular cloning of the Haemophilus influenzae gmhA (IpcA) gene encoding a phosphoheptose isomerase required for lipooligosaccharide biosynthesis, J. Bacteriol., 178, 3339-3341, 1996.
168. Raetz, C. R. H., Bacterial endotoxins: extraordinary lipids that activate eucaryotic signal transduction, J. Bacteriol., 175, 5745-5753, 1993.
169. Schnaitman, C. A. and Klena, J. D., Genetics of lipopolysaccharide biosynthesis in enteric bacteria, Microbiol. Rev., 57, 655-682, 1993.
170. Fleischmann, R. D., Adams, M. D., White, O., Clayton, R. A., Kirkness, E. F., Kerlavage, A. R., Bult, C. J., Tomb, J.-F., Dougherty, B. A., Merrick, J. M., McKenney, K., Sutton, G., FitzHugh, W., Fields, C., Gocayne, J. D., Scott, J., Shirley, R., Liu, L.-I., Glodek, A., Kelley, J. M., Weidman, J. F., Phillips, C. A., Spriggs, T., Hedblom, E., Cotton, M. D., Utterback, T. R., Hanna, M. C., Nguyen, D. T., Saudek, D. M., Brandon, R. C., Fine, L. D., Fritchman, J. L., Fuhrmann, J. L., Geoghagen, N. S., Gnehm, C. L., McDonald, L. A., Small, K. V., Fraser, C. M., Smith, H. O., and Venter, J. C., Whole-genome random sequencing and assembly of Haemophilus influenzae Rd, Science, 269, 496-512, 1995.
171. Levin, J. C. and Stein, D. C., Cloning, complementation, and characterization of an rfaE homolog from Neisseria gonorrhoeae, J. Bacteriol., 178, 4571-4575, 1996.
172. Drazek, E. S., Stein, D. C., and Deal, C. D., A mutation in the Neisseria gonorrhoeae rfaD homolog results in altered lipooligosaccharide expression, J. Bacteriol., 177, 2321-2327, 1995.
173. Coleman, W. G., The rfaD gene encodes for ADP-L-glycero-D-manno-heptose-6-epimerase. An enzyme required for lipopolysaccharide core biosynthesis, J. Biol. Chem., 258, 1985-1990, 1983.
174. Nichols, W. A., Gibson, B. W., Melaugh, W., Lee, N.-G., Sunshine, M., and Apicella, M. A., Identification of the ADP-L-glycero-D-mannno-heptose-6-epimerase (rfaD) and heptosyltransferase II (rfaF) biosynthesis genes from nontypeable Haemophilus influenzae 2019, Infect. Immun., 65, 1377-1386, 1997.
175. Shih, G. C., Kahler, C. M., Carlson, R. W., Rahman, M. M., Coleman, J., and Stephens, D. S., The ice-2 locus in Neisseria meningitidis: a polycistronic operon required in biosynthesis of lipooligosaccharide inner core and membrane phospholipids, in Abstracts of the Eleventh International Pathogenic Neisseria Conference, Nassif, X., Quentin-Millet, M.-J., Taha, M.-K., Eds., Nice, 28, 1998.
176. Zhou, D., Lee, N.-G., and Apicella, M. A., Lipooligosaccharide biosynthesis in Neisseria gonorrhoeae: cloning, identification and characterization of the α1,5 heptosyltransferase I gene (rfaC), Mol. Microbiol., 14, 609-618, 1994.
177. Stojiljkovic, I., Hwa, V., Larson, J., Lin, L., So, M., and Nassif, X., Cloning and characterization of the Neisseria meningitidis rfaC gene encoding α-1,5 heptosyltransferase I, FEMS. Microbiol. Lett., 151, 41-49, 1997.
178. Petricoin, E. F., III and Stein, D. C., Molecular analysis of lipooligosaccharides biosynthesis in Neisseria gonorrhoeae, Infect. Immun., 57, 2847-2852, 1989.
179. Petricoin, E. F., III, Danaher, R. J., and Stein, D. C., Analysis of the lsi region involved in lipooligosaccharide biosynthesis in Neisseria gonorrhoeae, J. Bacteriol., 173, 7896-7902, 1991.
180. Jennings, M. P., Bisercic, M., Dunn, K. L. R., Virji, M., Martin, A., Wilks, K. E., Richards, J. C., and Moxon, E. R., Cloning and molecular analysis of the lsi 1 (rfaF) gene of Neisseria meningitidis that encodes a heptosyl-2-transferase involved in LPS biosynthesis: evaluation of surface exposed carbohydrates in LPS mediated toxicity for human endothelial cells, Microb. Pathog., 19, 391-401, 1995.
181. Sandlin, R. C., Danaher, R. J., and Stein, D. C., Genetic basis of pyocin resistance in Neisseria gonorrhoeae, J. Bacteriol., 176, 6869-6876, 1994.
182. Schwan, E. T., Robertson, B. D., Brade, H., and van Putten, J. P. M., Gonococcal rfaF mutants express Rd2 chemotype LPS and do not enter epithelial host cells, Mol. Microbiol., 15, 267-275, 1995.
183. Kahler, C. M., Carlson, R. W., Rahman, M. M., Martin, L. E., and Stephens, D. S., Inner core biosynthesis of lipooligosaccharide in Neisseria meningitidis serogroup B: identification and role in LOS assembly of the α 1,2 N-acetylglucosamine transferase (rfaK), J. Bacteriol., 178, 1265-1273, 1996.
184. van der Ley, P., Kramer, M., Steeghs, L., Kuipers, B., Andersen, S. R., Jennings, M. P., Moxon, E. R. and Poolman, J. T., Identification of a locus invovled in meningococcal lipopolysaccharide biosynthesis by deletion mutagenesis, Mol. Microbiol., 19, 1117-1125, 1996.
185. Zhou, D., Stephens, D. S., Gibson, B. W., Engstrom, J. J., McAllister, C. F., Lee, F. K. N., and Apicella, M. A., Lipooligosaccharide biosynthesis in pathogenic Neisseria. Cloning, identification, and characterization of the phosphoglucomutase gene, J. Biol. Chem., 269, 11162-11169, 1994.
186. Dudas, K. C. and Apicella, M. A., Selection and immunochemical analysis of lipooligosaccharide mutants of Neisseria gonorrhoeae, Infect. Immun., 56, 499-504, 1988.
187. Stephens, D. S., McAllister, C. F., Zhou, D., Lee, F. K., and Apicella, M. A., Tn916-generated, lipooligosaccharide mutants of Neisseria meningitidis and Neisseria gonorrhoeae, Infect. Immun., 62, 2947-2952, 1994.
188. Kahler, C. M., Carlson, R. W., Rahman, M. M., Martin, L. E., and Stephens, D. S., Two glycosyltransferases, rfaK and lgtF, compose the ice (inner core extension) lipooligosaccharide biosynthesis operon in Neisseria meningitidis, J. Bacteriol., 178, 6677-6684, 1996.
189. van der Ley, P., Kramer, M., Martin, A., Richards, J. C., and Poolman, J. T., Analysis of the icsBA locus required for biosynthesis of the inner core region from Neisseria meningitidis, FEMS Microbiol. Lett., 146, 247-253, 1997.
190. Moran, A. P., Prendergast, M. M., and Appelmelk, B. J., Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease, FEMS Immunol. Med. Microbiol., 16, 105-115, 1996.
191. Jennings, M. P., van der Ley, P., Wilks, K. E., Maskell, D. J., Poolman, J. T., and Moxon, E. R., Cloning and molecular analysis of the galE gene of Neisseria meningitidis and its role in lipopolysaccharide biosynthesis, Mol. Microbiol., 10, 361-369, 1993.
192. Robertson, B. D., Frosch, M., and van Putten, J. P. M., The role of galE in the biosynthesis and function of gonococcal lipopolysaccharide, Mol. Microbiol., 8, 891-901, 1993.
193. Hammerschmidt, S., Birholz, C., Zahringer, U., Robertson, B. D., van Putten, J., Ebeling, O., and Frosch, M., Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis, Mol. Microbiol., 11, 885-896, 1994.
194. Petering, H., Hammerschmidt, S., Frosch, M., van Putten, J. P. M., Ison, C. A., and Robertson, B. D., Genes associated with the meningococcal capsule complex are also found in Neisseria gonorrhoeae, J. Bacteriol., 178, 3342-3345, 1996.
195. Lee, F. K. N., Stephens, D. S., Gibson, B. W., Engstrom, J. J., Zhou, D., and Apicella, M. A., Microheterogeneity of Neisseria lipooligosaccharide: analysis of a UDP-glucose 4-epimerase mutant of Neisseria meningitidis NMB, Infect. Immun., 63, 2508-2515, 1995.
196. Wakarchuk, W., Martin, A., Jennings, M., Moxon, E. R., and Richards, J. C., Functional relationships of the genetic locus encoding the glycosyltransferase enzymes involved in expression of the lacto-N-neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis, J. Biol. Chem., 271, 19166-19173, 1996.
197. Robertson, B. D., Frosch, M., and van Putten, J. P. M., The identification of cryptic rhamnose biosynthesis genes in Neisseria gonorrhoeae and their relationship to lipopolysaccharide biosynthesis, J. Bacteriol., 176, 6915-6920, 1994.
198. Gotschlich, E. C., Genetic locus for the biosynthesis of the variable portion of Neisseria gonorrhoeae lipooligosaccharide, J. Exp. Med., 180, 2181-2190, 1994.
199. Whitfield, C., Biosynthesis of lipopolysaccharide O antigens, Trends in Microbiol. 3, 178-185, 1995.
200. Post, D., Zaleski, A., Gibson, B. W., and Apicella, M. A., Identification of an undecaprenol kinase analog in Neisseria meningitidis serogroup B, in Abstracts of the Fifth Conference of the International Endotoxin Society, Santa Fe, 160, 1998.
201. Jennings, M. P., Hood, D. W., Peak, I. R. A., Virji, M., and Moxon, E. R., Molecular analysis of a locus for the biosynthesis and phase-variable expression of the lact-N-neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis, Mol. Microbiol., 18, 729-740, 1995.
202. Jennings, M. P., van der Ley, P., Kramer, M., Hood, D., Poolman, J. T., and Moxon, E. R., Lipopolysaccharide biosynthesis in Neisseria meningitidis: a genetic analysis of lgt loci in immunotype typing strains, in Abstracts of the Tenth International Pathogenic Neisseria Conference, Zollinger, W. D., Frasch, C. E. and Deal, C. D., Eds. Baltimore, 1996, 93-94.
203. Erwin, A. L., Haynes, P. A., Rice, P. A., and Gotschlich, E. C., Conservation of the lipooligosaccharide synthesis locus Igt among strain of Neisseria gonorrhoeae: requirement for lgtE in synthesis of the 2C7 epitope and of the β chain of strain 15253, J. Exp. Med., 184, 1233-1241, 1996.
204. Pavliak, V., Brisson, J.-R., Michon, F., Uhrin, D., and Jennings, H. J., Structure of the sialylated L3 lipopolysaccharide of Neisseria meningitidis, J. Biol. Chem., 268, 14146-14152, 1993.
205. Rest, R. F. and Mandrell, R. E., Neisserial sialyltransferases and their role in pathogenesis, Microb. Pathog., 19, 379-390, 1995.
206. Frosch, M., Edwards, U., Bousset, K., Krausse, B., and Weisgerber, C., Evidence for a common molecular origin of the capsule gene loci in Gram-negative bacteria expressing group II capsular polysaccharides, Mol. Microbiol., 5, 1251-1263, 1991.
207. Ganguli, S., Zapata, G., Wallis, T., Reid, C., Boulnois, G., Vann, W. F., and Roberts, I. S., Molecular cloning and analysis of genes for sialic acid synthesis in Neisseria meningitidis group B and purification of the meningococcal CMP-NeuNAc synthetase enzyme, J. Bacteriol., 176, 4583-4589, 1994.
208. Swartley, J. S. and Stephens, D. S., Identification of a genetic locus involved in the biosynthesis of N-acetyl-D-mannosamine, a precursor of the (α2-8)-linked polysialic acid capsule of serogroup B Neisseria meningitidis, J. Baceriol., 176, 1530-1534, 1994.
209. Swartley, J. S., Ahn, J. H., Liu, L.-J., Kahler, C. M., and Stephens, D. S., Expression of sialic acid and polysialic acid in serogroup B Neisseria meningitidis: divergent transcription of biosynthesis and transport operons through a common promoter region, J. Bacteriol., 178, 4052-4059, 1996.
210. Smith, H., Parsons, N. J., and Cole, J. A., Sialylation of neisseria lipopolysaccharide: a major influence on pathogenicity, Microbiol. Pathog., 19, 365-377, 1995.
211. Gilbert, M., Watson, D. C., Cunningham, A., Jennings, M. P., Young, N. M., and Wakarchuk, W. W., Cloning of the lipooligosaccharide α2,3 sialyltransferase from the bacterial pathogens Neisseria meningitidis and Neisseria gonorrhoeae, J. Biol. Chem., 271, 28271-28276, 1996.
212. Gilbert, M., Cunningham, A.-M., Watson, D. C., Martin, A., Richards, J. C., and Wakarchuk, W., Characterization of a recombinant Neisseria meningitidis α-2,3-sialylatransferase and its acceptor affinity, Eur. J. Biochem., 249, 187-194, 1997.
213. Banerjee, A., Wang, R., Uljon, S. N., Rice, P. A., Gotschlich, E. C., and Stein, D. C., Identification of the gene (IgtG) encoding the lipooligosacccharide β chain synthesizing glucosyl transferase from Neisseria meningitidis, Proc. Natl. Acad. Sci. U.S.A., 95, 10872-10877, 1998.
214. Galan, J. E. and Sansonetti, P. J., Molecular and cellular basis of Salmonella and Shigella interactions with host cells, in Escherichia coli and Salmonella Cellular and Molecular Biology, Neidhardt, F. C., Ed. ASM Press, Washington, D.C., 1996, 2757-2773.
215. Gulig, P. A., Pathogenesis of systemic disease, in Escherichia coli and Salmonella Cellular and Molecular Biology, Neidhardt, F. C., Ed. ASM Press, Washington, D.C., 1996, 2774-2787.
216. Mahan, M. J., Slauch, J. M. and Mekalanos, J. J., Selection for bacterial virulence genes that are specifically induced in host tissues, Science, 259, 666-668, 1993.
217. Morse, S. A., Miller, R. D. and Hebeler, B. H., Physiology and metabolism of Neisseria gonorrhoeae, in The Gonococcus, Roberts, R., Ed. John Wiley & Sons, New York, 1977, 213-253.
218. Morse, S. A., Cacciapuoti, A. F., and Lysko, P. G., Physiology of Neisseria gonorrhoeae, Adv. Micro. Phys., 20, 251-320, 1979.
219. Morse, S. A., Mintz, C. S., Sarafian, S. K., Bartenstein, L., Bertram, M. and Apicella, M. A., Effect of dilution rate on lipopolysaccharide and serum resistance of Neisseria gonorrhoeae grown in continuous culture, Infect. Immun., 41, 74-82, 1983.
220. Tsai, C.-M., Boykins, R., and Frasch, C. E., Heterogeneity and variation among Neisseria meningitidis lipopolysaccharides, J. Bacteriol., 155, 498-504, 1983.
221. Parsons, N. J., Emond, J.-P., Goldner, M., Bramley, J., Crooke, H., Cole, J. A., and Smith, H., Lactate enhancement of sialylation of gonococcal lipopolysaccharide and of induction of serum resistance by CMP-NANA is not due to direct activation of the sialyltransferase: metabolic events are involved, Microb. Pathog., 21, 193-204, 1996.
222. Frangipane, J. V. and Rest, R. F., Anaerobic growth and cytidine 5′-monophospho-N-acetyl-neuraminic acid act synergistically to induce high-level serum resistance in Neisseria gonorrhoeae, Infect. Immun., 61, 1657-1666, 1993.
223. Danaher, R. J., Levin, J. C., Arking, D., Burch, C. L., Sandlin, R., and Stein, D. C., Genetic basis of Neisseria gonorrhoeae lipooligosaccharide antigenic variation, J. Bacteriol., 177, 7275-7279, 1995.
224. Grunberg-Manago, M., regulation of the expression of aminoacyl-tRNA synthetases and translation factors, in Escherichia coli and Salmonella Cellular and Molecular Biology, Neidhardt, F. C., Ed. ASM Press, Washington, D.C., 1996, 1432-1457.
225. Keener, J. and Nomura, M., Regulation of ribosome synthesis, in Escherichia coli and Salmonella Cellular and Molecular Biology, Neidhardt, F. C., Ed. ASM Press, Washington, D.C., 1996, 1417-1431.
226. Gralla, J. D. and Collado-Vides, J., Organization and function of transcription regulatory elements, in Escherichia coli and Salmonella. Cellular and Molecular Biology, Neidhardt, F. C., Ed. ASM Press, Washington, D.C., 1996, 1232-1245.
227. Zhou, D., Zaleski, A., Buscher, B., Preston, A., and Apicella, M. A., A sixteen bp palindrome encompassing the putative ribosomal binding site is conserved in pathogenic Neisseria rfaC genes and is involved in the regulation of expression of meningococcal rfaC, in Abstracts of the Tenth International Pathogenic Neisseria Conference, Zollinger, W. D., Frasch, C. E., and Deal, C. D., Eds. Baltimore, 1996, 356.
228. Correia, F. F., Inouye, S., and Inouye, M., A family of small repeated elements with some transposon-like properties in the genome of Neisseria gonorrhoeae, J. Biol. Chem., 263, 12194-12198, 1988.
229. Rouquette, C. R., Balthazar, J. T., and Shafer, W. M., Neisseria meningitidis contains IS elements within the mtr operon, in 97th General Meeting American Society for Microbiology, Miami Beach, 1997, 60.
230. Liu, S. V., Liu, Y. B., and Rest, R. F., Upstream sequence variations and transcriptional regulation of sialyltransferase gene expression in pathogenic Neisseria, in Abstracts of the Eleventh International Pathogenic Neisseria Conference, Nassif, X., Quentin-Millet, M.-J., Taha, M.-K., Eds., 303, 1998.
231. Hubner, A. and Hendrickson, W., A fusion promoter created by a new insertion sequence, IS1490, activates transcription of 2,4,5-trichlorophenoxyacetic acid catabloic genes in Burkholderia cepacia AC1100, J. Bacteriol., 179, 2717-2723, 1997.
232. Prentki, P., Teter, B., Chandler, M., and Galas, D. J., Functional promoters created by the insertion of transposable element IS1, J. Mol. Biol., 191, 383-393, 1986.
233. van Putten, J. P. M., Phase variation of lipopolysaccharide directs interconversion of invasive and immuno-resistant phenotypes of Neisseria gonorrhoeae, EMBO J., 12, 4043-4051, 1993.
234. Burch, C. L., Danaher, R. J., and Stein, D. C., Antigenic variation in Neisseria gonorrhoeae: production of multiple lipooligosaccharides, J. Bacteriol., 179, 982-986, 1997.
235. Schneider, H., Griffiss, J. M., Boslego, J. W., Hitchcock, P. J., Zahos, K. M., and Apicella, M. A., Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men, J. Exp. Med., 174, 1601-1605, 1991.
236. Yang, Q.-L. and Gotschlich, E. C., Variation of gonococcal lipooligosaccharide structure is due to alterations in poly-G tracts in lgt genes encoding glycosyl transferases, J. Exp. Med., 183, 323-327, 1996.
237. Belland, R. J., Morrison, S. G., Carlson, J. H., and Hogan, D. M., Promoter strength influences phase variation of neisserial opa genes, Mol. Microbiol., 23, 123-135, 1997.
238. Apicella, M. A., Shero, M., Jarvis, G. A., Griffiss, J. M., Mandrell, R. E., and Schneider, H., Phenotypic variation in epitope expression of the Neisseria gonorrhoeae lipooligosaccharide, Infect. Immun., 55, 1755-1761, 1987.
239. Andersen, S. R., Bjune, G., Hoiby, E. A., Michaelsen, T. E., Aase, A., Rye, U., and Jantzen, E., Outer membrane vesicle vaccines made from short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis: effect of the carbohydrate chain length on the immune response, Vaccine, 15, 1225-1234, 1997.
240. Rosenqvist, E., Hoiby, E. A., Wedege, E., Bryn, K., Kolberg, J., Klem, A., Ronnild, E., Bjune, G., and Nokleby, H., Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine, Infect. Immun., 63, 4642-4652, 1995.
241. Meningococcal, Serogroup B Vaccine Protection Trial in Norway 1988-1991, NIPH Ann, 1991, 14, 47-250.
242. Idanpaan-Heikkila, I., Hoiby, E. A., Chattopadhyay, P., Airaksinen, U., Michaelsen, T. M., and Wedege, E., Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease, J. Med. Microbiol., 43, 335-343, 1995.
243. Guttormsen, H.-K., Wetzler, L. M., and Solberg, C. O., Humoral response to Class 1 outer membrane protein during the course of meningococcal disease, Infect. Immun., 62, 1437-1443, 1994.
244. Otsuka, A., Hanafusa, T., Kono, N., and Tarai, S., Lipopolysaccharide augments HLA-A,B,C molecule expression but inhibits interferon-gamma-induced HLA-DR molecule expression on cultures human endothelial cells, Immunology, 71, 428-432, 1991.
245. Pollack, M., Espinoza, A. M., Guelde, G., Koles, N. L., Wahl, L. M., and Ohl, C. A., Lipopolysaccharide (LPS)-specific monoclonal antibodies regulate LPS uptake and LPS-induced tumor necrosis factor-α responses by human monocytes, J. Infect. Dis., 172, 794-804, 1995.
246. Hicks, C. B., Boslego, J. W., and Brandt, B., Evidence of serum antibodies to Neisseria gonorrhoeae before gonococcal infection, J. Infect. Dis., 155, 1276-1281, 1987.
247. Mandrell, R. E. and Zollinger, W. D., Human immune response to meningococcal outer membrane protein epitopes after natural infection or vaccination, Infect. Immun., 57, 1590-1598, 1989.
248. Sjursen, H., Wedege, E., Rosenqvist, E., Naess, A., Halstensen, A., Matre, R., and Solberg, C. O., IgG subclass antibodies to serogroup B meningococcal outer membrane antigens following infection and vaccination, APMIS, 98, 1061-1069, 1990.
249. Estabrook, M. E., Mandrell, R. E., Apicella, M. A., and Griffiss, J. M., Measurement of the human immune response to meningococcal lipooligosaccharide antigens by using serum to inhibit monoclonal antibody binding to purified lipooligosaccharide, Infect. Immun., 58, 2204-2213, 1990.
250. Estabrook, M. M., Baker, C. J., and Griffiss, J. M., The immune response of children to meningococcal lipooligosaccharides during disseminated disease is directed primarily against two monoclonal antibody-defined epitopes, J. Infect. Dis., 167, 966-970, 1993.
251. Saukkonen, K., Leinonen, M., Abdillahi, H., and Poolman, J. T., Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay, Vaccine, 7, 325-328, 1989.
252. Verheul, A. F. M., Boons, G. J. P. H., van der Marel, G. A., van Boom, J. H., Jennings, H. J., Snippe, H., Verhoef, J., Hoogerhout, P., and Poolman, J. T., Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugates, Infect. Immun., 59, 3566-3573, 1991.
253. Verheul, A. F. M., van Gaans, J. A. M., Wiertz, E. J. H., Snippe, H., Verhoff, J., and Poolman, J. T., Meningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein - but not LPS-specific bactericidal antibodies in mice: influence of adjuvants, Infect. Immun., 61, 187-196, 1993.
254. Gu, X.-X. and Tsai, C.-M., Preparation, characterization, and immunogenicity of meningococcol lipooligosaccharide-derived oligosaccharide-protein conjugates, Infection and Immunity, 61, 1873-1880, 1993.
255. Milagres, L. G., Brandileone, M. C. C., Sacchi, C. T., Vieira, V. S. D., Zanella, R. C., and Frasch, C. E., Antibody studies in mice of outer membrane antigens for use in an improved meningococcal B and C vaccine, FEMS Immunol. Med. Microbiol., 13, 9-17, 1996.
256. Petrov, A. B., Semenov, B. F., Vartanyan, Y. P., Zakirov, M. M., Torchilin, V. P., Trubetskoy, V. S., Koshkina, N. V., L'vov, V. L., Verner, I. K., Lopyrev, I. V., and Dmitriev, B. A., Toxicity and immunogenicity of Neisseria meningitidis lipopolysaccharide incorporated into liposomes, Infect. Immun., 60, 3897-3903, 1992.
257. Petrov, A. B., Kolenko, V. M., Koshkina, N. V., Zakirov, M. M., Bugaev, L. V., Semenova, I. B., Wiertz, E. J. H. J., and Poolman, J. T., Non-specific modulation of the immune response with liposomal meningococcal lipopolysaccharide: role of different cells and cytokines, Vaccine, 12, 1064-1070, 1993.
258. Difabio, J. L., Michon, F., Brisson, J. R., and Jennings, H. J., Structures of the L1 and L6 core oligosaccharide epitopes of Neisseria meningitidis, Can. J. Chem., 68, 1029-1034, 1990.
259. Gamain, A., Beurret, M., Michon, F., Brisson, J.-R., and Jennings, H. J., Structure of the L2 lipopolysaccharide core oligosaccharides of Neisseria meningitidis, J. Biol. Chem., 267, 922-925, 1992.
260. Dell, A., Azadi, P., Tiller, P., and Thomas-Oates, J., Analysis of oligosaccharides epitopes of meningococcal lipopolysaccharides by fast-atom-bombardment mass spectrometry, Carbohydr. Res., 200, 59-76, 1990.
261. Michon, F., Beurret, M., Gamian, A., Brisson, J.-R., and Jennings, H. J., Structure of the L5 lipopolysaccharide core oligosaccharides of Neisseria meningitidis, J. Biol. Chem., 265, 7243-7247, 1990.
262. Gilbert, M., Cunningham, A.-M., Watson, D. C., Martin, A., Richards, J. C. and Wakarchuk, W. W., Characterization of a recombinant Neisseria meningitidis α-2,3-sialyltransferase and its acceptor specificity, Eur. J. Biochem., 249, 187-194, 1997.
263. Yamasaki, R., Nasholds, W., Schneider, H., and Apicella, M. A., Epitope expression and partial structural characterization of F62 lipooligosaccharide (LOS) of Neisseria gonorrhoeae: IgM monoclonal antibodies (3F11 and 1-1-M) recognize non-reducing termini of the LOS components, Mol. Immunol., 28, 133-124, 1991.